Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
International Urology and Nephrology|March 23, 2012
Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?Mehmet Kanbay, Mahmut Ilker Yilmaz, Baris Afsar, et al.
Kidney International|July 9, 2010
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney diseaseMahmut I Yilmaz, Alper Sonmez, Mutlu Saglam, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 30, 2010
Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?Mahmut Ilker Yilmaz, Alper Sonmez, Mutlu Saglam, et al.
Transplantation|February 24, 2007
Endothelial dysfunction and fetuin A levels before and after kidney transplantationKayser Caglar, Mahmut Ilker Yilmaz, Mutlu Saglam, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2011
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trialMahmut Ilker Yilmaz, Alper Sonmez, Mutlu Saglam, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 13, 2009
Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney diseaseMahmut Ilker Yilmaz, Juan Jesús Carrero, Alberto Ortiz, et al.
Atherosclerosis|April 16, 2015
Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult menKadir Ozturk, Ahmet Uygun, Ahmet Kerem Guler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
The relationship between hemoglobin levels and endothelial functions in diabetes mellitusAlper Sonmez, Mahmut Ilker Yilmaz, Mutlu Saglam, et al.
Pageof 8